← Back to Search

Bladder Pressure Monitoring Device for Neurogenic Bladder

N/A

Waitlist Available

Led By Chris Cooper, MD

Research Sponsored by Christopher Cooper

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must have diagnosed neurogenic bladder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during uds testing

Awards & highlights

Study Summary

This trial is testing a new pressure-monitoring device for urinary catheters. The goal is to see if it's as accurate as the current gold-standard measurement method.

Who is the study for?

This trial is for individuals who have been diagnosed with neurogenic bladder and are already scheduled to undergo urodynamics testing as part of their standard care. There are no specific exclusion criteria mentioned, so it appears open to all patients meeting the inclusion conditions.Check my eligibility

What is being tested?

The study is evaluating a new pressure monitoring device that attaches to urinary catheters. The goal is to see if this novel device can measure bladder pressure accurately when compared with the established method of urodynamics testing.See study design

What are the potential side effects?

Since the trial involves non-invasive monitoring with an external device during a routine test, there may be minimal or no additional side effects beyond those associated with standard urodynamics testing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with a neurogenic bladder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during uds testing

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during uds testing

This trial's timeline: 3 weeks for screening, Varies for treatment, and during uds testing for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Bladder Pressure

Trial Design

1Treatment groups

Experimental Treatment

Group I: Neurogenic Bladder PatientsExperimental Treatment1 Intervention

Patients with neurogenic bladder undergoing urodynamics testing

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Christopher CooperLead Sponsor

1 Previous Clinical Trials

50 Total Patients Enrolled

Chris Cooper, MDPrincipal InvestigatorMD

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies in this research protocol for new participants?

"As per clinicaltrials.gov, this medical trial is not presently seeking participants. It was first published on April 15th 2018 and has been most recently amended as of May 17th 2022. At the moment, there are 33 other trials that are currently recruiting patients for study participation."

Answered by AI

Is it possible for me to enroll in this clinical experiment?

"Eligibility criteria for this medical trial include being between the ages of 1 and 99, having neurogenic bladder issues, and having a maximum number of 100 participants."

Answered by AI

Is this investigation accepting volunteers that are of legal age?

"This clinical trial has established a participant age range of 1 to 99 years old. Furthermore, 13 studies are devoted to those younger than 18 and 24 for elderly individuals above 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing

Christopher Cooper 2018. "Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03456089.